HealthEquity (HQY) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
25 Jun, 2026Opening remarks and agenda
Meeting called to order by the chairman, with board members and executive officers present virtually.
Agenda and rules of conduct made available through the virtual portal.
Inspector of election and independent auditor representatives introduced.
Corporate governance
Quorum established with 95.13% of shares represented in person or by proxy.
Voting conducted on five proposals, including director elections and plan approvals.
Advanced notice provision in bylaws confirmed; nominations for directors closed.
Board and executive committee updates
Ten directors nominated for election, with terms until the 2027 annual meeting.
Board recommended approval for all proposals on the agenda.
Partial view of Summaries dataset, powered by Quartr API
Latest events from HealthEquity
- Net income up 29%, Adjusted EBITDA margin at 46%, and buybacks and guidance increased.HQY
Q1 2027 - Board recommends all proposals amid strong financials and enhanced governance and ESG oversight.HQY
Proxy filing - Key votes include board elections, auditor ratification, and approval of compensation and equity plans.HQY
Proxy filing - Record HSA and revenue growth, margin expansion, and raised guidance signal strong momentum.HQY
Q4 2026 - Digital innovation, AI, and margin expansion fuel strong HSA growth and robust financial outlook.HQY
44th Annual J.P. Morgan Healthcare Conference - CEO transition to Scott Cutler set for January 2025, with strong growth and innovation focus.HQY
Investor Update - Revenue up 23%, net income up 239%, and $300M buyback announced for Q2 FY25.HQY
Q2 2025 - Q1 FY25 delivered double-digit revenue and EBITDA growth, with raised guidance and record HSA gains.HQY
Q1 2025 - Record FY25 revenue and HSA growth drive strong results and a positive FY26 outlook.HQY
Q4 2025